Wird geladen...
Hepatitis C Vaccines, Antibodies, and T Cells
The development of vaccines that protect against persistent hepatitis C virus (HCV) infection remain a public health priority. The broad use of highly effective direct-acting antivirals (DAAs) is unlikely to achieve HCV elimination without vaccines that can limit viral transmission. Two vaccines tar...
Gespeichert in:
| Veröffentlicht in: | Front Immunol |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6031729/ https://ncbi.nlm.nih.gov/pubmed/30002657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01480 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|